127 related articles for article (PubMed ID: 21273240)
1. In search of early events in the development of chronic kidney disease: the emerging role for lipocalin-2/NGAL.
Rauen T; Weiskirchen R; Floege J
Nephrol Dial Transplant; 2011 Feb; 26(2):445-7. PubMed ID: 21273240
[No Abstract] [Full Text] [Related]
2. Neutrophil gelatinase-associated lipocalin (NGAL) as a new biomarker for non--acute kidney injury (AKI) diseases.
Giasson J; Li GH; Chen Y
Inflamm Allergy Drug Targets; 2011 Aug; 10(4):272-82. PubMed ID: 21539515
[TBL] [Abstract][Full Text] [Related]
3. [NGAL: a biomarker of acute and chronic renal dysfunction].
Lalanne A; Beaudeux JL; Bernard MA
Ann Biol Clin (Paris); 2011; 69(6):629-36. PubMed ID: 22123561
[TBL] [Abstract][Full Text] [Related]
4. [The role of neutrophil gelatinase-associated lipocalin (NGAL) in the glycolipid metabolism and inflammation].
Zhu RT; Gong JP
Sheng Li Ke Xue Jin Zhan; 2012 Jun; 43(3):198-201. PubMed ID: 23019923
[No Abstract] [Full Text] [Related]
5. [NGAL, biomarker of acute kidney injury in 2012].
Gagneux-Brunon A; Delanaye P; Legrand D; Cavalier E; Mariat C
Nephrol Ther; 2012 Dec; 8(7):508-15. PubMed ID: 22541989
[TBL] [Abstract][Full Text] [Related]
6. Plasma neutrophil gelatinase-associated lipocalin and kidney function decline and kidney disease-related clinical events in older women.
Lim WH; Lewis JR; Wong G; Teo R; Lim EM; Byrnes E; Prince RL
Am J Nephrol; 2015; 41(2):156-64. PubMed ID: 25824561
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic utility of neutrophil gelatinase-associated lipocalin (NGAL) in patients with cardiovascular diseases--review.
Helanova K; Spinar J; Parenica J
Kidney Blood Press Res; 2014; 39(6):623-9. PubMed ID: 25531230
[TBL] [Abstract][Full Text] [Related]
8. Acute kidney injury in critically ill infants: the role of urine Neutrophil Gelatinase-Associated Lipocalin (NGAL).
Mussap M; Degrandi R; Fravega M; Fanos V
J Matern Fetal Neonatal Med; 2010 Oct; 23 Suppl 3():70-2. PubMed ID: 20807163
[TBL] [Abstract][Full Text] [Related]
9. A possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis.
Takahashi T; Asano Y; Noda S; Aozasa N; Akamata K; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Tada Y; Sugaya M; Kadono T; Sato S
Br J Dermatol; 2015 Sep; 173(3):681-9. PubMed ID: 25781362
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil gelatinase-associated lipocalin (NGAL): a new piece of the anemia puzzle?
Bolignano D; Coppolino G; Donato V; Lacquaniti A; Bono C; Buemi M
Med Sci Monit; 2010 Jun; 16(6):RA131-5. PubMed ID: 20512104
[TBL] [Abstract][Full Text] [Related]
11. Lipocalin-2: pro- or anti-apoptotic?
Kehrer JP
Cell Biol Toxicol; 2010 Apr; 26(2):83-9. PubMed ID: 19160065
[TBL] [Abstract][Full Text] [Related]
12. [Novel biological involvements of siderophore-binding proteins in hematopoiesis, cell differentiation, tissue injury, carcinogenesis and infections].
Mori K; Mukoyama M; Nakao K
Rinsho Ketsueki; 2009 Jul; 50(7):519-26. PubMed ID: 19638718
[No Abstract] [Full Text] [Related]
13. Lipocalin 2 regulation and its complex role in inflammation and cancer.
Li C; Chan YR
Cytokine; 2011 Nov; 56(2):435-41. PubMed ID: 21855366
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil gelatinase-associated lipocalin in cancer.
Lippi G; Meschi T; Nouvenne A; Mattiuzzi C; Borghi L
Adv Clin Chem; 2014; 64():179-219. PubMed ID: 24938019
[TBL] [Abstract][Full Text] [Related]
15. Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney disease.
Shen SJ; Hu ZX; Li QH; Wang SM; Song CJ; Wu DD; He JL; Guan JC; Shan JP
Nephrology (Carlton); 2014 Mar; 19(3):129-35. PubMed ID: 24397346
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil gelatinase associated lipocalin in acute kidney injury.
Peacock WF; Maisel A; Kim J; Ronco C
Postgrad Med; 2013 Nov; 125(6):82-93. PubMed ID: 24200764
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention.
Liebetrau C; Gaede L; Doerr O; Blumenstein J; Rixe J; Teichert O; Willmer M; Weber M; Rolf A; Möllmann H; Hamm C; Nef H
Scand J Clin Lab Invest; 2014 Mar; 74(2):81-8. PubMed ID: 24304491
[TBL] [Abstract][Full Text] [Related]
18. Renal stress in vivo in real-time--visualised by the NGAL reporter mouse.
Haase M; Mertens PR; Haase-Fielitz A
Nephrol Dial Transplant; 2011 Jul; 26(7):2109-11. PubMed ID: 21555391
[No Abstract] [Full Text] [Related]
19. NGAL can alternately mediate sunitinib resistance in renal cell carcinoma.
Yu DS; Wu CL; Ping SY; Huang YL; Shen KH
J Urol; 2014 Aug; 192(2):559-66. PubMed ID: 24423438
[TBL] [Abstract][Full Text] [Related]
20. Novel preprocedural and acute-phase postprocedural predictive factors for contrast-induced kidney injury in CKD patients.
Okumura N; Hayashi M; Ishii H; Yoshikawa D; Yasuda Y; Goto M; Matsuo S; Oiso Y; Murohara T
Int J Cardiol; 2014 Mar; 172(2):e293-6. PubMed ID: 24480182
[No Abstract] [Full Text] [Related]
[Next] [New Search]
